Loading…
Functional analysis of ESRP1/2 gene variants and CTNND1 isoforms in orofacial cleft pathogenesis
Orofacial cleft (OFC) is a common human congenital anomaly. Epithelial-specific RNA splicing regulators ESRP1 and ESRP2 regulate craniofacial morphogenesis and their disruption result in OFC in zebrafish, mouse and humans. Using esrp1/2 mutant zebrafish and murine Py2T cell line models, we functiona...
Saved in:
Published in: | Communications biology 2024-08, Vol.7 (1), p.1040-14 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Orofacial cleft (OFC) is a common human congenital anomaly. Epithelial-specific RNA splicing regulators
ESRP1
and
ESRP2
regulate craniofacial morphogenesis and their disruption result in OFC in zebrafish, mouse and humans. Using
esrp1/2
mutant zebrafish and murine Py2T cell line models, we functionally tested the pathogenicity of human
ESRP1/2
gene variants. We found that many variants predicted by in silico methods to be pathogenic were functionally benign.
Esrp1
also regulates the alternative splicing of
Ctnnd1
and these genes are co-expressed in the embryonic and oral epithelium. In fact, over-expression of
ctnnd1
is sufficient to rescue morphogenesis of epithelial-derived structures in
esrp1/2
zebrafish mutants. Additionally, we identified 13
CTNND1
variants from genome sequencing of OFC cohorts, confirming
CTNND1
as a key gene in human OFC. This work highlights the importance of functional assessment of human gene variants and demonstrates the critical requirement of
Esrp
-
Ctnnd1
acting in the embryonic epithelium to regulate palatogenesis.
ESRP1, ESRP2 and CTNND1 operate in the periderm to regulate craniofacial morphogenesis. Using complementary in vivo and in vitro models, we tested the function of human ESRP1/2 gene variants and CTNND1 isoforms |
---|---|
ISSN: | 2399-3642 2399-3642 |
DOI: | 10.1038/s42003-024-06715-3 |